In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.

Incyte Corporation (NASDAQ:INCY) is one of the most undervalued biotech stocks to buy right now. RBC Capital raised the price ...

Telix Pharmaceuticals Ltd (ASX:TLX) has delivered a sharp reminder of how quickly sentiment can swing in biotech — with a ...

Seaport Therapeutics, a Boston biotech led by Daphne Zohar, has filed to go public, setting up a Nasdaq debut that could funnel fresh cash into its neuropsychiatric drug pipeline. Spun out of PureTech ...

Specialized laboratory relocation firm shares safety protocols and planning tips for moving precision instruments in ...

Initial results from a high-stakes trial indicate the biotech may have finally found a niche in lymphoma care for a ...

Chinese biotech firms are striking big global deals as drug makers, but could artificial intelligence take them to the next ...

After being knocked back in 2024, serial biotech acquirer Kevin Tang has used a different route to finally get his hands on Kezar Life Sciences.   | Autoimmune specialist Aurinia, which named Kevin ...

Profusa (PFSA) shares jumped 173% following announcement of $30M equity deal to acquire PanOmics diagnostics platform from BioInsights LLC.

Climb Bio, Inc. stays a Buy on budoprutug pMN data; Phase 2 PrisMN readout 2H 2026 + SLE/ITP upside and 2028 cash runway.

Biogen’s lupus drug candidate litifilimab has improved outcomes in another phase 2 trial, adding to the momentum behind a program barreling toward pivotal data in two forms of t ...

Another bidder, which remains unidentified, dropped out of the bidding process. Analysts at William Blair now think it ...